Lower EphB3 levels may correlate with more aggressive or invasive tumor phenotypes, Expression decreases in migratory and less stem-like tumor cell populations; EprhinB3 likely supports normal Eph receptor signaling dynamics without actively driving tumor progression. This evidence concerns the gene EPHB3 and neoplasm.